Fairman Group Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Russell 1000 Growth ETF
VONG
|
+$4.66M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$837K |
| 3 |
W.R. Berkley
WRB
|
+$417K |
| 4 |
AbbVie
ABBV
|
+$199K |
| 5 |
Vanguard Russell 1000 Value ETF
VONV
|
+$192K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Essent Group
ESNT
|
+$832K |
| 2 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$480K |
| 3 |
Accenture
ACN
|
+$358K |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$251K |
| 5 |
Pfizer
PFE
|
+$126K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.45% |
| 2 | Financials | 8.79% |
| 3 | Healthcare | 1.18% |
| 4 | Consumer Discretionary | 1.17% |
| 5 | Industrials | 1.08% |
No holdings matched the selected filter criteria.
Similar funds
Fairman Group's Q2 2026 Portfolio in Review
As of Q2 2026, Fairman Group held 343 positions worth $127M, up 8.8% from $117M the previous quarter. Its ten largest holdings account for 65% of the portfolio.
Fairman Group deployed $4.8M of net new capital in Q2 2026, opening 17 new positions and adding to 67 existing holdings. Its largest new stake was Vanguard Russell 1000 Value ETF: 1,876 shares worth $199K.
By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Essent Group, an estimated $832K trimmed.
- Fairman Group's largest Q2 2026 buy was Vanguard Russell 1000 Value ETF: 1,876 shares worth $199K.
- Fairman Group added most to Vanguard Russell 1000 Growth ETF in Q2 2026, an estimated $4.66M increase.
- Fairman Group's biggest Q2 2026 reduction was Essent Group, cutting an estimated $832K.
- Fairman Group fully exited Blackstone Secured Lending in Q2 2026, selling an estimated $35.5K.
- Fairman Group's ten largest holdings make up 65% of its $127M portfolio in Q2 2026.
- Fairman Group opened 17 new positions and closed 11 in Q2 2026.
- Fairman Group's portfolio value rose 8.8% quarter-over-quarter to $127M.
Based on Fairman Group's 13F filing for Q2 2026, filed 4 Aug 2026.